President Trump on Friday signed a roughly $1 trillion omnibus spending bill that funds the federal government through Sept. 30 and includes a $2 billion funding increase for NIH.
The House approved the spending bill on Wednesday in a 309-118 vote, and the Senate on Thursday voted 79-18 to approve the measure. Democrats largely viewed the spending deal as a win, while some conservative lawmakers said they were disappointed in the measure.
The spending package does not include several budget priorities the White House detailed in March, such as a $1.2 billion cut to funding for NIH research and new funding for a wall that Trump has vowed to build along the United States' border with Mexico. The spending agreement also will increase funding for the military and for border security, but not at the levels Trump had sought.
Health care allocations
Under the spending agreement, NIH will receive a $2 billion funding increase over the next five months, including an additional:
- $476 million for the National Cancer Institute;
- $400 million for Alzheimer's disease research;
- $120 million for former President Barack Obama's All of Us Research Program, formerly known as the Precision Medicine Initiative, as it seeks to recruit volunteers for genetic testing and health tracking; and
- $110 million for Obama's Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative to support efforts to map the human brain.
The spending agreement also will hike funding for programs to fight the United States' opioid misuse epidemic, from $150 million to about $800 million.
In addition, the spending agreement:
- Permanently extends retired coal miners' health care benefits, which had been at risk of shutting down;
- Preserves federal funding for Planned Parenthood through the remainder of FY 2017; and
- Provides $295 million for Puerto Rico's Medicaid program (Ballhaus, Wall Street Journal, 5/5; Fabian, The Hill, 5/5).
Health care reform beyond the ACA—join us on May 9 to learn the implications of a consumer-driven marketplace
Stuart Clark, Managing Director
Today’s consumers have both the financial motivation and knowledge necessary to reward providers who can efficiently fulfill their health care needs, and a broad array of non-traditional competitors are setting the new competitive standard for access, service, and convenience.
This webconference explores the drivers and implications of this new consumer-driven marketplace, especially the unprecedented levels of financial exposure, transparency, and choice. The presentation also includes the latest strategic guidance on how hospital and health system leaders should proceed amid uncertainty.